Kiniksa Pharmaceuticals International, plc (KNSA) › Operating IncomeKiniksa Pharmaceuticals International, plc (KNSA) — Operating IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$65.40M2018-12-31: -$108.16M2019-12-31: -$169.96M2020-12-31: -$157.36M2021-12-31: -$156.64M2022-12-31: $9.77M2023-12-31: -$25.20M2024-12-31: -$45.62M2025-12-31: $77.22M$77.22M2017-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$77.22M—2026-02-24From 2025-01-012024-12-31-$45.62M—2026-02-24From 2024-01-012023-12-31-$25.20M-357.8%2026-02-24From 2023-01-012022-12-31$9.77M—2025-02-25From 2022-01-012021-12-31-$156.64M—2024-02-28From 2021-01-012020-12-31-$157.36M—2023-03-02From 2020-01-012019-12-31-$169.96M—2022-02-24From 2019-01-012018-12-31-$108.16M—2021-02-25From 2018-01-012017-12-31-$65.40M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)